Compound ID | 1315
Class: Fluoroquinolone
| Spectrum of activity: | Gram-negative |
| Details of activity: | Antofloxacin hydrochloride demonstrates clinical and bacteriological efficacies similar to levofloxacin for the treatment of AECB and AP. |
| Institute where first reported: | Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100083, China. |
| Year first mentioned: | 2008 |
| Highest developmental phase: | Phase 2 |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|